Ostuka Of Japan Ends IPO Debut 1.9 Percent Above Asking Price
This article was originally published in PharmAsia News
Japan's Otsuka Holdings barely surpassed its highly touted initial public offering target, enough to make it the largest IPO on record for a pharmaceutical company
You may also be interested in...
A round up of news from around the biopharma sector and its efforts to meet the challenges posed by the coronavirus pandemic.
The US FDA published on 29 March an emergency temporary guidance that relaxes oversight of certain sterilizers, disinfectant devices and air purifiers intended to kill the SARS-CoV-2 virus. See what the agency said about it here.
Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies
Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.